<?xml version='1.0' encoding='utf-8'?>
<document id="30096607"><sentence text="Simultaneous determination of the novel anti-tumor candidate drug MDH-7 and 5-fluorouracil in rat plasma by LC-MS/MS: Application to pharmacokinetic interactions."><entity charOffset="76-90" id="DDI-PubMed.30096607.s1.e0" text="5-fluorouracil" /></sentence><sentence text="MDH-7 (2,3,9-tri-O-acetyl-5,6-dideoxy-1,10-di-[N4'-pentoxycarbonyl-5'-fluoro cytosine]-4-ulose 1,4: 7,10-difuranose-4,8-pyranose) is a novel anti-tumor drug candidate"><entity charOffset="0-128" id="DDI-PubMed.30096607.s2.e0" text="MDH-7 (2,3,9-tri-O-acetyl-5,6-dideoxy-1,10-di-[N4'-pentoxycarbonyl-5'-fluoro cytosine]-4-ulose 1,4: 7,10-difuranose-4,8-pyranose" /></sentence><sentence text=" To study the pharmacokinetic interaction between MDH-7 and 5-fluorouracil (5-FU), a sensitive and rapid liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was developed to simultaneously determine the concentrations of MDH-7 and 5-fluorouracil (5-FU) in rat plasma"><entity charOffset="60-74" id="DDI-PubMed.30096607.s3.e0" text="5-fluorouracil" /><entity charOffset="76-80" id="DDI-PubMed.30096607.s3.e1" text="5-FU" /><entity charOffset="244-258" id="DDI-PubMed.30096607.s3.e2" text="5-fluorouracil" /><entity charOffset="260-264" id="DDI-PubMed.30096607.s3.e3" text="5-FU" /><pair ddi="false" e1="DDI-PubMed.30096607.s3.e0" e2="DDI-PubMed.30096607.s3.e0" /><pair ddi="false" e1="DDI-PubMed.30096607.s3.e0" e2="DDI-PubMed.30096607.s3.e1" /><pair ddi="false" e1="DDI-PubMed.30096607.s3.e0" e2="DDI-PubMed.30096607.s3.e2" /><pair ddi="false" e1="DDI-PubMed.30096607.s3.e0" e2="DDI-PubMed.30096607.s3.e3" /><pair ddi="false" e1="DDI-PubMed.30096607.s3.e1" e2="DDI-PubMed.30096607.s3.e1" /><pair ddi="false" e1="DDI-PubMed.30096607.s3.e1" e2="DDI-PubMed.30096607.s3.e2" /><pair ddi="false" e1="DDI-PubMed.30096607.s3.e1" e2="DDI-PubMed.30096607.s3.e3" /><pair ddi="false" e1="DDI-PubMed.30096607.s3.e2" e2="DDI-PubMed.30096607.s3.e2" /><pair ddi="false" e1="DDI-PubMed.30096607.s3.e2" e2="DDI-PubMed.30096607.s3.e3" /></sentence><sentence text=" Plasma samples were prepared by simple liquid-liquid extraction with ethyl acetate"><entity charOffset="70-83" id="DDI-PubMed.30096607.s4.e0" text="ethyl acetate" /></sentence><sentence text=" Chromatographic separation was performed on a Waters XBridge™ C18 column (5 μm, 2" /><sentence text="1 mm × 150 mm) with the mobile phase of methanol and H2O (80:20, v/v)"><entity charOffset="40-48" id="DDI-PubMed.30096607.s6.e0" text="methanol" /><entity charOffset="53-56" id="DDI-PubMed.30096607.s6.e1" text="H2O" /><pair ddi="false" e1="DDI-PubMed.30096607.s6.e0" e2="DDI-PubMed.30096607.s6.e0" /><pair ddi="false" e1="DDI-PubMed.30096607.s6.e0" e2="DDI-PubMed.30096607.s6.e1" /></sentence><sentence text=" The ESI positive and negative ion switch was operated in the multiple reactions monitoring (MRM) mode" /><sentence text=" The calibration curves showed good linearity (r2 &gt; 0" /><sentence text="99) over the ranges of 50-8000 ng/mL for MDH-7 and 10-2000 ng/mL for 5-FU, respectively"><entity charOffset="69-73" id="DDI-PubMed.30096607.s9.e0" text="5-FU" /></sentence><sentence text=" The lower limit of quantitations (LLOQs) was 50 ng/mL (MDH-7) and 10 ng/mL (5-FU) with relative standard deviation (RSD) &lt; 13"><entity charOffset="77-80" id="DDI-PubMed.30096607.s10.e0" text="5-FU" /></sentence><sentence text="0%" /><sentence text=" The proposed method was successfully applied to simultaneous assessment of pharmacokinetic drug-drug interaction between MDH-7 and 5-FU in rats"><entity charOffset="132-136" id="DDI-PubMed.30096607.s12.e0" text="5-FU" /></sentence><sentence text="" /></document>